Norheim, Frode
Chella Krishnan, Karthickeyan
Bjellaas, Thomas
Vergnes, Laurent
Pan, Calvin
Parks, Brian W
Meng, Yonghong
Lang, Jennifer
Ward, James A
Reue, Karen
Mehrabian, Margarete
Gundersen, Thomas E
Péterfy, Miklós
Dalen, Knut T
Drevon, Christian A
Hui, Simon T
Lusis, Aldons J https://orcid.org/0000-0001-9013-0228
Seldin, Marcus M https://orcid.org/0000-0001-8026-4759
Funding for this research was provided by:
HHS | NIH | National Heart, Lung, and Blood Institute (HL138193)
HHS | NIH | National Heart, Lung, and Blood Institute (HL28481)
HHS | NIH | National Heart, Lung, and Blood Institute (HL30568)
HHS | NIH | National Heart, Lung, and Blood Institute (HL69766)
HHS | NIH | National Heart, Lung, and Blood Institute (HL144651)
Norwegian Research Council (240405/F20)
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK120875)
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK097771)
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK117850)
American Heart Association (18POST33990256)
Article History
Received: 4 May 2020
Revised: 31 October 2020
Accepted: 10 November 2020
First Online: 8 January 2021
Conflict of interest
: T.B, T.E.G, and C.A.D are affiliated with Vitas Ltd. T.B and T.E.G are employed and stock owners, whereas C.A.D is board member, stock owner, and consultant in Vitas. Vitas Ltd. performed the lipidomics analyses. The other authors declare no conflict of interests.